These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23925953)

  • 1. Development of a human antibody tolerant mouse model to assess the immunogenicity risk due to aggregated biotherapeutics.
    Bi V; Jawa V; Joubert MK; Kaliyaperumal A; Eakin C; Richmond K; Pan O; Sun J; Hokom M; Goletz TJ; Wypych J; Zhou L; Kerwin BA; Narhi LO; Arora T
    J Pharm Sci; 2013 Oct; 102(10):3545-55. PubMed ID: 23925953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a transgenic mouse model to study the immunogenicity of recombinant human insulin.
    Torosantucci R; Brinks V; Kijanka G; Halim LA; Sauerborn M; Schellekens H; Jiskoot W
    J Pharm Sci; 2014 May; 103(5):1367-74. PubMed ID: 24619587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of ADA against recombinant human interferon beta in immune tolerant mice requires rapid recruitment of CD4⁺ T cells, induces formation of germinal centers but lacks susceptibility for (most) adjuvants.
    Kijanka G; Sauerborn M; Boon L; Schellekens H; Brinks V
    J Pharm Sci; 2015 Feb; 104(2):396-406. PubMed ID: 25219665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid transgenic immune tolerant mouse model for assessing the breaking of B cell tolerance by human interferon beta.
    van Beers MM; Sauerborn M; Gilli F; Hermeling S; Brinks V; Schellekens H; Jiskoot W
    J Immunol Methods; 2010 Jan; 352(1-2):32-7. PubMed ID: 19857496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response against Betaferon® in immune tolerant mice: involvement of marginal zone B-cells and CD4+ T-cells and apparent lack of immunological memory.
    Sauerborn M; van Beers MM; Jiskoot W; Kijanka GM; Boon L; Schellekens H; Brinks V
    J Clin Immunol; 2013 Jan; 33(1):255-63. PubMed ID: 22945588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune syndrome after induction of neonatal tolerance to alloantigens: effects of in vivo treatment with anti-T cell subset monoclonal antibodies.
    Merino J; Schurmans S; Luzuy S; Izui S; Vassalli P; Lambert PH
    J Immunol; 1987 Sep; 139(5):1426-31. PubMed ID: 3114366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose levels in particulate-containing formulations impact anti-drug antibody responses to murine monoclonal antibody in mice.
    Shomali M; Tanriverdi S; Freitag AJ; Engert J; Winter G; Siedler M; Kaymakcalan Z; Carpenter JF; Randolph TW
    J Pharm Sci; 2015 May; 104(5):1610-21. PubMed ID: 25737325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive Chemical Modifications in the Primary Protein Structure of IgG1 Subvisible Particles Are Necessary for Breaking Immune Tolerance.
    Boll B; Bessa J; Folzer E; Ríos Quiroz A; Schmidt R; Bulau P; Finkler C; Mahler HC; Huwyler J; Iglesias A; Koulov AV
    Mol Pharm; 2017 Apr; 14(4):1292-1299. PubMed ID: 28206769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to Mitigate the Unwanted Immunogenicity of Therapeutic Proteins during Drug Development.
    Salazar-Fontana LI; Desai DD; Khan TA; Pillutla RC; Prior S; Ramakrishnan R; Schneider J; Joseph A
    AAPS J; 2017 Mar; 19(2):377-385. PubMed ID: 28083796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural characterization and immunogenicity in wild-type and immune tolerant mice of degraded recombinant human interferon alpha2b.
    Hermeling S; Aranha L; Damen JM; Slijper M; Schellekens H; Crommelin DJ; Jiskoot W
    Pharm Res; 2005 Dec; 22(12):1997-2006. PubMed ID: 16184451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune syndrome after induction of neonatal tolerance to alloantigens. CD4+ T cells from the tolerant host activate autoreactive F1 B cells.
    Merino J; Schurmans S; Duchosal MA; Izui S; Lambert PH
    J Immunol; 1989 Oct; 143(7):2202-8. PubMed ID: 2570803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation.
    Hermeling S; Schellekens H; Maas C; Gebbink MF; Crommelin DJ; Jiskoot W
    J Pharm Sci; 2006 May; 95(5):1084-96. PubMed ID: 16552750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modified immune tolerant mouse model to study the immunogenicity of recombinant human interferon beta.
    Abdolvahab MH; Brinks V; Schellekens H
    J Immunol Methods; 2014 Dec; 415():17-23. PubMed ID: 25450255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses in mice to particles formed from adsorption of a murine monoclonal antibody onto glass microparticles.
    Shomali M; Freitag A; Engert J; Siedler M; Kaymakcalan Z; Winter G; Carpenter JF; Randolph TW
    J Pharm Sci; 2014 Jan; 103(1):78-89. PubMed ID: 24227137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of antigenic potency in vitro and immunogenicity in vivo by coupling the antigen to anti-immunoglobulin.
    Kawamura H; Berzofsky JA
    J Immunol; 1986 Jan; 136(1):58-65. PubMed ID: 3079611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo generation and function of B cells in the presence of a monoclonal anti-IgM antibody: implications for B cell tolerance.
    Gause A; Yoshida N; Kappen C; Rajewsky K
    Eur J Immunol; 1987 Jul; 17(7):981-90. PubMed ID: 3497044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of a pokeweed mitogen-stimulated plaque-forming cell response by a human B lymphocyte-derived aggregated IgG-stimulated suppressor factor: suppressive B cell factor (SBF).
    Pisko EJ; Foster SL; White RE; Panetti M; Turner RA
    J Immunol; 1986 Mar; 136(6):2141-50. PubMed ID: 2419423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell-dependent suppression of antibody production. I. Characteristics of suppressor T cells following tolerance induction.
    Basten A; Miller JF; Loblay R; Johnson P; Gamble J; Chia E; Pritchard-Briscoe H; Callard R; McKenzie IF
    Eur J Immunol; 1978 May; 8(5):360-70. PubMed ID: 308454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
    Majlessi L; Bordenave G
    Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.